FDA Panel To Discuss Safety Of Contrast Agents In June
This article was originally published in The Pink Sheet Daily
Executive Summary
Endocrinologic and Metabolic Drugs Advisory Committee will convene in July to address role of cardiovascular assessment in type 2 diabetes.